Wikipedia -WSS

Wikipedia

author：explore 2025-09-30 01:14:00 - browse：85

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Vermont grapples with historic flooding as more rainstorms head for Northeast

focus

WSS

NYU Langone launches private ChatGPT for its health care data

Appeals court upholds limits to abortion pill

Cuban government calls US nuclear submarine stop a 'provocative escalation'

EU fines Illumina $475 million over Grail acquisition

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Superbugs, antibiotic resistance get scrutiny in congress

leisure time

Wikipedia

focus

Affirmative action in medical school literally saved lives

Britney Spears to release memoir, 'The Woman In Me,' later this year

Virginia high school admissions case could be legal follow

EU fines Illumina $475 million over Grail acquisition

23andMe had bad news about my health. I wish a person had delivered it

Watch the official trailer for 'Ahsoka' series

23andMe had bad news about my health. I wish a person had delivered it

Diversity in medical illustrations gets boost from Chidiebere Ibe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Radiation, mainstay of cancer treatment, begins a fade

entertainment

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

How to make AI work for medicine

As pharma fights Medicare drug negotiation, hospitals, docs silent

Grail's uphill battle for Medicare to cover its cancer screening test

Blinken talks high

How Long Island became the ‘eugenics capital of the world’

focus

entertainment

explore

focus